Slocum, Gordon & Co’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Slocum, Gordon & Co's JNJ Position: Q3 2026 in Review
Slocum, Gordon & Co reduced its Johnson & Johnson (JNJ) stake by 5.2% in Q3 2026, selling an estimated $584K and leaving 40,277 shares worth $10.7M. The position accounts for 7.44% of the portfolio, ranked #2.
Slocum, Gordon & Co first reported a position in JNJ in Q4 2022 and has held it in 16 quarters since. The position peaked at $12M in Q4 2022. 4,700 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.
- Slocum, Gordon & Co held 40,277 shares of Johnson & Johnson worth $10.7M as of Q3 2026.
- Slocum, Gordon & Co sold 2,212 Johnson & Johnson shares in Q3 2026, an estimated $584K.
- Johnson & Johnson made up 7.44% of Slocum, Gordon & Co's portfolio in Q3 2026, its #2 holding.
- Slocum, Gordon & Co first reported a position in Johnson & Johnson in Q4 2022 and has held it in 16 quarters since.
- Slocum, Gordon & Co's Johnson & Johnson position peaked at $12M in Q4 2022.
- 4,700 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.
Based on Slocum, Gordon & Co's 13F filing for Q3 2026, filed 19 Oct 2026.